ID   B1(NG)C39D
AC   CVCL_1N73
SY   AG13177
DR   CLO; CLO_0022090
DR   Coriell; AG13177
DR   Wikidata; Q54752273
RX   CelloPub=CLPUB00597;
RX   PubMed=2321096;
RX   PubMed=2791350;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N71 ! B1 [Mouse embryonal carcinoma]
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
RX   CelloPub=CLPUB00597;
RG   National Institute on Aging;
RT   "1994 catalog of cell lines. NIA Aging Cell Repository.";
RL   (In misc. document) Institute for Medical Research (Camden, N.J.); pp.1-351; National Institutes of Health; Bethesda; USA (1994).
//
RX   PubMed=2321096; DOI=10.1007/BF01233049;
RA   Littlefield J.W., Whitehouse L.L.;
RT   "Absence of uvomorulin in a slowly compacting variant of H6 embryonal
RT   carcinoma cells.";
RL   Somat. Cell Mol. Genet. 16:191-194(1990).
//
RX   PubMed=2791350; DOI=10.1002/dvg.1020100403;
RA   Littlefield J.W.;
RT   "Compaction-defective embryonal carcinoma cell variants.";
RL   Dev. Genet. 10:292-297(1989).
//